WA 335 (danitracen): a preliminary evaluation of a potential antidepressant compound. A comparative double-blind study with WA 335 and amitriptyline in the treatment of depressive patients
- Curr Ther Res Clin Exp. 1977 Jan;21(1):108-13.
PMID: 401705
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT ReceptorResearch Areas: Neurological Disease